Researchers at the Swedish Neuroscience Institute in Washington and Novartis Pharma revealed that Gilenya (fingolimod) induced a [...]
MS does not remit and the out dated term causes many people to delay taking medication, says Dr Patricia Coyle, Founder and Director of [...]
Research from Indiana University School of Medicine showed that D3T – a compound that triggers copying of antioxidant genes and [...]
Positive results from a home-based exercise intervention designed to target flexibility, toning, and balance for older adults with multiple [...]
Genentech, a member of the Roche Group, was founded more than 35 years ago and has been focused on a variety of research fields, including [...]
Results from a Phase 2 clinical trial showed that five-year clinical outcomes of patients with highly active relapsing-remitting multiple [...]
